Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter]
Infection and Drug Resistance · 2026-05 · Volume 19 · 1-3
DOI: 10.2147/idr.s609305 ↗Kurz gefasst
Leserbrief in der Zeitschrift Infection and Drug Resistance, 2026-05. Verfasst von Dimitra Peppa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection and Immunity, University College London, London, UK. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Infection and Immunity, University College London, London, UK.
- Mortimer Market Centre, Department of HIV, CNWL NHS Trust, London, UK.
- The Ian Charleson Day Centre, Royal Free London NHS Foundation Trust, London, UK.
- Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
- Department of HIV Medicine, Royal Free Hospital NHS Foundation Trust, London, UK.
ORCID-Profile: Dimitra Peppa
Förderung
- NIAID NIH HHS
Zitieren
APA
Peppa, D., Alrubayyi, A., & Bhagani, S. (2026). Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter]. Infection and Drug Resistance, Volume 19, 1-3. https://doi.org/10.2147/idr.s609305
Vancouver
Peppa D, Alrubayyi A, Bhagani S. Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter]. Infection and Drug Resistance. 2026;Volume 19:1-3. doi:10.2147/idr.s609305
BibTeX
@article{Peppa2026,
author = {Peppa, Dimitra and Alrubayyi, Aljawharah and Bhagani, Sanjay},
title = {Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter]},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--3},
doi = {10.2147/idr.s609305}
}
EUVIMED